NEW YORK, Nov. 08, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Rayonier Advanced Materials Inc. (NYSE:RYAM), Health Insurance Innovations, Inc. (NASDAQ:HIIQ), Columbus McKinnon Corporation (NASDAQ:CMCO), A. O. Smith Corporation (NYSE:AOS), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), and Altice USA, Inc. (NYSE:ATUS), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
RYAM DOWNLOAD: http://MarketSourceResearch.com/register/?so=RYAM
HIIQ DOWNLOAD: http://MarketSourceResearch.com/register/?so=HIIQ
CMCO DOWNLOAD: http://MarketSourceResearch.com/register/?so=CMCO
AOS DOWNLOAD: http://MarketSourceResearch.com/register/?so=AOS
PCRX DOWNLOAD: http://MarketSourceResearch.com/register/?so=PCRX
ATUS DOWNLOAD: http://MarketSourceResearch.com/register/?so=ATUS
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Market Source Research, available for free download at the links above, examine Rayonier Advanced Materials Inc. (NYSE:RYAM), Health Insurance Innovations, Inc. (NASDAQ:HIIQ), Columbus McKinnon Corporation (NASDAQ:CMCO), A. O. Smith Corporation (NYSE:AOS), Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX), and Altice USA, Inc. (NYSE:ATUS) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed November 6th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
RAYONIER ADVANCED MATERIALS INC. (RYAM) REPORT OVERVIEW
Rayonier Advanced Materials' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Rayonier Advanced Materials reported revenue of $541.72MM vs $201.23MM (up 169.21%) and analysts estimated basic earnings per share $0.97 vs $0.03 (up 3,133.33%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Rayonier Advanced Materials reported revenue of $961.33MM vs $868.73MM (up 10.66%) and analysts estimated basic earnings per share $7.17 vs $1.61 (up 345.34%). Analysts expect earnings to be released on February 19th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.50. The estimated EPS forecast for the next fiscal year is $2.10 and is expected to report on February 19th, 2019.
To read the full Rayonier Advanced Materials Inc. (RYAM) report, download it here: http://MarketSourceResearch.com/register/?so=RYAM
-----------------------------------------
HEALTH INSURANCE INNOVATIONS, INC. (HIIQ) REPORT OVERVIEW
Health Insurance Innovations' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Health Insurance Innovations reported revenue of $74.01MM vs $63.34MM (up 16.86%) and analysts estimated basic earnings per share $0.24 vs $0.33 (down 27.27%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Health Insurance Innovations reported revenue of $250.48MM vs $184.52MM (up 35.75%) and analysts estimated basic earnings per share $1.63 vs $0.59 (up 176.27%). Analysts expect earnings to be released on February 27th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.26. The estimated EPS forecast for the next fiscal year is $2.56 and is expected to report on February 27th, 2019.
To read the full Health Insurance Innovations, Inc. (HIIQ) report, download it here: http://MarketSourceResearch.com/register/?so=HIIQ
-----------------------------------------
COLUMBUS MCKINNON CORPORATION (CMCO) REPORT OVERVIEW
Columbus McKinnon's Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Columbus McKinnon reported revenue of $217.14MM vs $212.83MM (up 2.03%) and analysts estimated basic earnings per share $0.68 vs $0.55 (up 23.64%). For the twelve months ended March 31st, 2018 vs March 31st, 2017, Columbus McKinnon reported revenue of $839.42MM vs $637.12MM (up 31.75%) and analysts estimated basic earnings per share $0.97 vs $0.44 (up 120.45%). Analysts expect earnings to be released on February 5th, 2019. The report will be for the fiscal period ending December 31st, 2018. Reported EPS for the same quarter last year was $0.44. The estimated EPS forecast for the next fiscal year is $3.13 and is expected to report on May 29th, 2019.
To read the full Columbus McKinnon Corporation (CMCO) report, download it here: http://MarketSourceResearch.com/register/?so=CMCO
-----------------------------------------
A. O. SMITH CORPORATION (AOS) REPORT OVERVIEW
A. O. Smith's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, A. O. Smith reported revenue of $833.30MM vs $738.20MM (up 12.88%) and basic earnings per share $0.67 vs $0.53 (up 26.42%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, A. O. Smith reported revenue of $2,996.70MM vs $2,685.90MM (up 11.57%) and analysts estimated basic earnings per share $1.72 vs $1.87 (down 8.02%). Analysts expect earnings to be released on January 29th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.60. The estimated EPS forecast for the next fiscal year is $2.83 and is expected to report on January 29th, 2019.
To read the full A. O. Smith Corporation (AOS) report, download it here: http://MarketSourceResearch.com/register/?so=AOS
-----------------------------------------
PACIRA PHARMACEUTICALS, INC. (PCRX) REPORT OVERVIEW
Pacira Pharmaceuticals' Recent Financial Performance
For the three months ended September 30th, 2018 vs September 30th, 2017, Pacira Pharmaceuticals reported revenue of $83.45MM vs $67.34MM (up 23.93%) and analysts estimated basic earnings per share -$0.02 vs -$0.19. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Pacira Pharmaceuticals reported revenue of $286.63MM vs $276.37MM (up 3.71%) and analysts estimated basic earnings per share -$1.07 vs -$1.02. Analysts expect earnings to be released on February 27th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.18. The estimated EPS forecast for the next fiscal year is $0.00 and is expected to report on February 27th, 2019.
To read the full Pacira Pharmaceuticals, Inc. (PCRX) report, download it here: http://MarketSourceResearch.com/register/?so=PCRX
-----------------------------------------
ALTICE USA, INC. (ATUS) REPORT OVERVIEW
Altice's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Altice reported revenue of $2,364.15MM vs $2,322.36MM (up 1.80%) and analysts estimated basic earnings per share -$0.13 vs -$0.73. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Altice reported revenue of $9,326.57MM vs $6,017.21MM (up 55.00%) and analysts estimated basic earnings per share $2.18 vs -$1.28. Analysts expect earnings to be released on February 26th, 2019. The report will be for the fiscal period ending December 31st, 2018. The reported EPS for the same quarter last year was $0.00. The estimated EPS forecast for the next fiscal year is $0.21 and is expected to report on February 26th, 2019.
To read the full Altice USA, Inc. (ATUS) report, download it here: http://MarketSourceResearch.com/register/?so=ATUS
-----------------------------------------
ABOUT MARKET SOURCE RESEARCH
Market Source Research delivers the key research reports that helps serious investors, registered brokers, professional traders, and personal investment advisers find reliable information in today's markets. Market Source Research's team is comprised of financial professionals, many of which hold Chartered Financial Analyst® (CFA®) designations and FINRA® BrokerCheck® certifications. Whether identifying emerging trends, or discovering new opportunity, the team at Market Source Research is dedicated to providing accurate, informative, and objective content that's ahead of the curve. With insights on individual companies as well as sectors, readers get the industry's best available combination of big-picture perspective as well as granular detail.
REGISTERED MEMBER STATUS
Market Source Research's oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Market Source Research's roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Market Source Research have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Market Source Research's Compliance department by Phone, at +1 (704) 343-6361, or by E-mail at compliance@MarketSourceResearch.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Market Source Research, Market Source Research members, and/or Market Source Research affiliates are not responsible for any gains or losses that result from the opinions expressed. Market Source Research makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Market Source Research has not been compensated for the publication of this press release by any of the above mentioned companies. Market Source Research is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Hugo Moreau, Media Department
Office: +1 (704) 343-6361
E-mail: media@MarketSourceResearch.com
© 2018 Market Source Research. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@MarketSourceResearch.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.